Live Breaking News & Updates on Higuchi Biosciences Center|Page 4

Stay updated with breaking news from Higuchi biosciences center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KU lab leads research on little-studied coronavirus structure

Developing antiviral treatment ....

Anthony Fehr , Erik Lundquist , University Of Kansas , Biomedical Research Excellence , Chemical Biology Of Infectious Disease Center , Alphavirus Treatment At Johns Hopkins University , National Institutes Of Health , National Institutes Of Health Research Project Grant , University Of Iowa , Protein Structurex Ray Crystallography Laboratory , Ku Center , Ku Infectious Disease Assay Development , Development Of Macrodomain Inhibitors For Coronavirus , Structural Biology Center , Higuchi Biosciences Center , Higuchi Biosciences , Chemical Biology , Infectious Disease Center , Biomedical Research , National Institutes , Disease Assay Development , Health Research Project Grant , Macrodomain Inhibitors , Alphavirus Treatment , Johns Hopkins , Chemical Biology Core ,

KU research award recipients working toward treatments for Parkinson's disease, development of new antibacterial agents

KU research award recipients working toward treatments for Parkinson's disease, development of new antibacterial agents
ku.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ku.edu Daily Mail and Mail on Sunday newspapers.

United States , Valentinoj Stella , Eduardo Rosa Molinar , John Jay , Shawn Burdette , Michael Johnson , Inez Jay , Scott Lovell , Michael Hageman , Shyam Sathyamoorthi , Josephine Chandler , Davidk Johnson , Foundation Distinguished Professor , Inez Jay Fund , National Institutes Of Health , Kansas Vaccine Institute , Ku Microscopy Analytical Imaging Laboratory , Development Of New Antibacterial Agents , Worcester Polytechnic Institute , Ku Biopharmaceutical Innovation Optimization Center , Ku Computational Chemical Biology Core Laboratory , Inez Jay Research Fund , Jay Fund , Higuchi Biosciences Center , Ku Protein Structurex Ray Crystallography Laboratory , Pharmaceutical Chemistry ,

Reviva: Developing Next-Generation Antipsychotic Drug

Share:
Schizophrenia is the most common psychotic disease with a global prevalence in about 1% of the population, affecting approximately 3.5 million people in the U.S. and 20 million globally. Despite the high prevalence, there is currently no therapy that adequately addresses the complex mental disorder.
Current antipsychotics prescribed for schizophrenia are plagued with suboptimal efficacy, poor tolerability, adverse effects and abnormally high dropout rates.
As a result of suboptimal efficacy, the major symptoms of schizophrenia, such as chronic mood symptoms and cognitive dysfunction, are not adequately addressed to date. In addition, approved antipsychotics are reported to cause adverse effects at varying degrees including extrapyramidal symptoms (EPS), akathisia, obesity, diabetes, cholesterol and sexual dysfunction. ....

Higuchi Biosciences Center , Laxminarayan Bhat , Negative Syndrome Scale , Superior Safety , ஹிகுச்சி உயிர் அறிவியல் மையம் , லக்ஷ்மிநாராயண் பட் , எதிர்மறை நோய்க்குறி அளவு ,